- Crime Lab
- Crime Scene
- Death Penalty
- Digital Forensic Insider
- Digital Forensics
- Evidence Collection
- Expert Forensic Voices
- Forensic Anthropology
- Forensic Psychology
- Impression Evidence
- Medical Examiner
- Mobile Forensics
- Police Procedure
- Sexual Assault Investigations
- Witness Testimony
A New Era in Forensic Analysis: Introducing Illumina’s MiSeq FGx™ Forensic Genomics System
Now Available ON DEMAND
Duration: 60 Minutes
In the past 20 years, forensic DNA analysis has become an indispensable tool in the criminal justice system. Yet despite improvements in chemistry sensitivity and process automation, data generation has remained relatively unchanged. Currently, routine analysis is restricted to the length of STR alleles and only 10’s of markers can be combined in a single system. Comprehensive sample interrogation requires intensive workflows/methods and multiple parallel analyses.
The advent of Next Generation Sequencing (NGS) promises a genomic leap forward in forensic science. NGS addresses the shortcomings of conventional methods and dramatically expands investigative capabilities. For the first time, autosomal STRs can be analyzed simultaneously with other types of STRs, and a range of SNPs. Compatibility with established criminal databases is maintained, while the data obtained is substantially increased. Now, investigative leads can be generated from cold cases with no suspect and no database hits.
To leverage these enhanced NGS lead generating capabilities, labs will require intuitive instrumentation and streamlined, application-specific software. The MiSeqFGx system delivers these specifications and more. And with the flexibility of the NGS platform to support a diverse range of applications, the potential for expanded capabilities is extensive.
We invite you to join us on the journey to advance forensic science.
- Explore the potential of NGS for forensic analysis.
- Learn about the MiSeqFGx and its data generation capabilities.
- Review real world sample data sequenced on the MiSeqFGx System.M
Market Development Manager Illumina
Associate Professor in Pharmacogenetics
National Board of Forensic Medicine, Sweden